BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25003294)

  • 1. Dysplasia in ulcerative colitis as a predictor of unsuspected synchronous colorectal cancer.
    Murphy J; Kalkbrenner KA; Pemberton JH; Landmann RG; Heppell JP; Young-Fadok TM; Etzioni DA
    Dis Colon Rectum; 2014 Aug; 57(8):993-8. PubMed ID: 25003294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the likelihood of colorectal cancer when surgery for ulcerative-colitis-associated dysplasia is deferred?
    Murphy J; Kalkbrenner KA; Blas JV; Pemberton JH; Landmann RG; Young-Fadok TM; Etzioni DA
    Colorectal Dis; 2016 Jul; 18(7):703-9. PubMed ID: 26921877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most dysplasia in ulcerative colitis is visible at colonoscopy.
    Rutter MD; Saunders BP; Wilkinson KH; Kamm MA; Williams CB; Forbes A
    Gastrointest Endosc; 2004 Sep; 60(3):334-9. PubMed ID: 15332019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity.
    Awais D; Siegel CA; Higgins PD
    Gut; 2009 Nov; 58(11):1498-503. PubMed ID: 19651634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-gated fluorescence spectroscopy improves endoscopic detection of low-grade dysplasia in ulcerative colitis.
    Ortner MA; Fusco V; Ebert B; Sukowski U; Weber-Eibel J; Fleige B; Stolte M; Oberhuber G; Rinneberg H; Lochs H
    Gastrointest Endosc; 2010 Feb; 71(2):312-8. PubMed ID: 20003972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted?
    Gorfine SR; Bauer JJ; Harris MT; Kreel I
    Dis Colon Rectum; 2000 Nov; 43(11):1575-81. PubMed ID: 11089596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplasia in inflammatory bowel disease.
    Greenson JK
    Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
    Löfberg R
    Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
    Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
    Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis.
    Bernstein CN; Weinstein WM; Levine DS; Shanahan F
    Am J Gastroenterol; 1995 Dec; 90(12):2106-14. PubMed ID: 8540497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?
    Blonski W; Kundu R; Lewis J; Aberra F; Osterman M; Lichtenstein GR
    Scand J Gastroenterol; 2008; 43(6):698-703. PubMed ID: 18569987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences.
    van den Broek FJ; Stokkers PC; Reitsma JB; Boltjes RP; Ponsioen CY; Fockens P; Dekker E
    Am J Gastroenterol; 2014 May; 109(5):715-22. PubMed ID: 21427710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The malignant side of chronic inflammatory bowel disease].
    West RL; van de Vrie W; Schouten WR; van Dekken H; Kuipers EJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2521-4. PubMed ID: 12532661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
    Stenling R; Lindberg J; Rutegård J; Palmqvist R
    APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysplasia and cancer in ulcerative colitis: a soluble problem?
    Riddell RH
    Scand J Gastroenterol Suppl; 1984; 104():137-49. PubMed ID: 6597546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of Colorectal Cancer Surveillance in Patients with Ulcerative Colitis: 38 Years' Experience in a Patient Cohort from a Defined Population Area.
    Rutegård M; Palmqvist R; Stenling R; Lindberg J; Rutegård J
    Scand J Surg; 2017 Jun; 106(2):133-138. PubMed ID: 27431978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.
    Gearry RB; Wakeman CJ; Barclay ML; Chapman BA; Collett JA; Burt MJ; Frizelle FA
    Dis Colon Rectum; 2004 Mar; 47(3):314-22. PubMed ID: 14991493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.